News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
692,545 Results
Type
Article (39391)
Company Profile (247)
Press Release (652907)
Section
Business (204027)
Career Advice (2005)
Deals (35407)
Drug Delivery (93)
Drug Development (80950)
Employer Resources (169)
FDA (16134)
Job Trends (14829)
News (344885)
Policy (32473)
Tag
Academia (2535)
Alliances (49314)
Alzheimer's disease (1314)
Approvals (16118)
Artificial intelligence (199)
Bankruptcy (357)
Best Places to Work (11637)
Biotechnology (175)
Breast cancer (225)
Cancer (1710)
Cardiovascular disease (128)
Career advice (1669)
CAR-T (121)
Cell therapy (353)
Clinical research (65249)
Collaboration (659)
Compensation (370)
COVID-19 (2563)
C-suite (160)
Data (1629)
Diabetes (211)
Diagnostics (6282)
Earnings (85436)
Employer resources (146)
Events (110863)
Executive appointments (564)
FDA (17035)
Funding (602)
Gene therapy (245)
GLP-1 (648)
Government (4357)
Healthcare (18767)
Infectious disease (2674)
Interviews (310)
IPO (16461)
Job creations (3628)
Job search strategy (1420)
Layoffs (437)
Legal (7885)
Lung cancer (255)
Manufacturing (235)
Medical device (13262)
Medtech (13267)
Mergers & acquisitions (19321)
Metabolic disorders (548)
Neuroscience (1715)
NextGen: Class of 2025 (6509)
Non-profit (4475)
Northern California (2090)
Obesity (306)
Opinion (193)
Patents (162)
People (56828)
Phase I (20316)
Phase II (28748)
Phase III (21402)
Pipeline (711)
Postmarket research (2562)
Preclinical (8576)
Radiopharmaceuticals (241)
Rare diseases (321)
Real estate (5897)
Regulatory (21917)
Research institute (2311)
Resumes & cover letters (349)
Southern California (1791)
Startups (3567)
United States (18436)
Vaccines (611)
Weight loss (208)
Date
Last 7 days (593)
Last 30 days (2459)
Last 365 days (34385)
2025 (4427)
2024 (35218)
2023 (40077)
2022 (51175)
2021 (55710)
2020 (54083)
2019 (46539)
2018 (35023)
2017 (32113)
2016 (31481)
2015 (37553)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29264)
2010 (27328)
Location
Africa (716)
Arizona (211)
Asia (37505)
Australia (6132)
California (4761)
Canada (1715)
China (392)
Colorado (217)
Connecticut (230)
Europe (80387)
Florida (688)
Georgia (165)
Illinois (455)
Indiana (259)
Japan (121)
Maryland (739)
Massachusetts (3602)
Michigan (198)
Minnesota (334)
New Jersey (1347)
New York (1359)
North Carolina (833)
Northern California (2090)
Ohio (173)
Pennsylvania (1098)
South America (1093)
Southern California (1791)
Texas (701)
Utah (143)
Washington State (467)
692,545 Results for "veru inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Weight loss
Veru’s Drug Spares Lean Mass in Overweight, Obese Adults on Wegovy—Is It Enough?
Patients taking Novo Nordisk’s Wegovy plus Veru’s enobosarm saw 71% lower lean mass loss than those who were taking Wegovy alone but investors await more data.
January 27, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Veru Reports Fiscal 2025 First Quarter Financial Results and Clinical Program Progress
February 13, 2025
·
27 min read
Press Releases
Veru to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference
February 4, 2025
·
13 min read
BioMidwest
Veru to Present at the 2024 Jefferies Global Healthcare Conference
Veru Inc. announced that Mitchell Steiner, M.D., Chairman, President and Chief Executive Officer of Veru, will present an update of Veru’s Phase 2b clinical program of enobosarm to augment fat loss and to avoid muscle loss when combined with GLP-1 drugs for weight loss at the Jefferies Global Healthcare Conference on Wednesday, June 5, 2024 at 11:00 am – 11:25 am ET.
May 22, 2024
·
10 min read
Press Releases
Veru to Report Fiscal 2025 First Quarter Financial Results on February 13, 2025
February 6, 2025
·
13 min read
BioMidwest
Veru Adjourns 2024 Annual Meeting of Shareholders to June 27, 2024
Veru Inc. announced that its Annual Meeting of Shareholders scheduled for today was convened and adjourned without any business being conducted due to lack of a required quorum.
June 18, 2024
·
7 min read
BioMidwest
Veru to Present at the American Diabetes Association’s 84th Scientific Sessions
Veru Inc. announced that the Company will present two presentations at the American Diabetes Association’s 84th Scientific Sessions, taking place June 21-24, 2024, in Orlando, Florida.
June 10, 2024
·
10 min read
Press Releases
Veru Announces the Sale of the FC2 Female Condom® (Internal Condom) Business
December 31, 2024
·
10 min read
Veru Announces Safety and Body Composition Data from Two Late-Breaker Presentations at the American Diabetes Association’s 84th Scientific Sessions
Veru Inc. (NASDAQ: VERU) today announced data from two late-breaker presentations at the American Diabetes Association’s 84th Scientific Sessions, which took place on June 21-24, 2024, in Orlando, Florida.
June 24, 2024
·
11 min read
Veru to Present at the GLP-1 Based Therapeutics Summit
Veru Inc. today announced that the Company has been invited to give a presentation at the GLP-1 Based Therapeutics Summit, taking place May 15-16, 2024, in Philadelphia, PA.
May 2, 2024
·
7 min read
1 of 69,255
Next
